Premium Information is available for this item - Upgrade for $1 a day
6550-01-608-1016
Antibody Enhancement Test Reagent
6550016081016 016081016 8E22-02
INC: 41949 Antibody Enhancement Test Reagent
January 2023
4
Marketplace 6550-01-608-1016
Request a Quotation from participating marketplace vendors
Related Documents 6550-01-608-1016 2+ Documents (More...)
Antibody Enhancement Test Reagent 016081016 6550-01-608-1016 2+ Documents ( More... ) https//www.nsnlookup.com
/fsg-65/fsc-6550/us 6550-01-608-1016 Antibody Enhancement Test Restrictions 6550-01-608-1016 DEMIL
Antibody Enhancement Test Reagent 016081016 6550-01-608-1016 2+ Documents ( More... ) https//www.nsnlookup.com
/fsg-65/fsc-6550/us 6550-01-608-1016 /fsg-65/fsc-6550/us 6550-01-608-1016 Antibody Enhancement Test
Restrictions 6550-01-608-1016
6550-01-608-1016 is a Antibody Enhancement Test Reagent Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6550-01-608-1016
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6550-01-608-1016
- France (ZF01)
- Effective Date:
- 1 Aug 2012
Approved Sources 6550-01-608-1016
- Part Number
- Manufacturer
- Status
- 8E22-02
- Manufacturer
- 1KF01 - Diasorin Inc (Active)
- Primary Buy
- Primary Buy
- 8E22-02
- FB0B2 - Diasorin Sa (Active)
- Secondary Buy
- Secondary Buy
Similar Supply Items to 6550-01-608-1016
Freight Information 6550-01-608-1016
6550-01-608-1016 has freight characteristics.. 6550-01-608-1016 has a variance between NMFC and UFC when transported by rail and the description should be consulted.